Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by Relaxrelaxon Mar 31, 2017 3:53pm
254 Views
Post# 26060355

The Story Hasn't Changed

The Story Hasn't ChangedNope, not a CA or banker but I do know a good story when I see it.  They aren't having trouble getting investors.  8.5% loan for $25 million payable by 2022 is very reasonable.  As for the warrants, they are only exercisable if the stock price goes above $3.70.  We could only hope they can excercise them! The we've all made a 70% profit from yesterday's closing price!
Lol!
Bullboard Posts